Auspex Raises Series B

Auspex Pharmaceuticals, a Vista, Calif.-based biotech startup focused on targeted deuteration of clinically validated drugs, has raised $13.88 million in Series B funding. Thomas, McNerney & Partners led the round, and was joined by return backers CMEA Ventures and Costa Verde Capital. www.auspexpharma.com